Author

Dmitry S. Loginov

Czech Academy of SciencesORCID 0000-0002-4164-6145Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:protein folding & dynamics· 2 Research Focus:drug response / drug discovery· 1 Assay:protein structure· 1 Assay:structural biology· 1

Frequent Co-Authors

Pavla VaňkováiD· 3 shared Petr ManiD· 3 shared Angel Luis PeyiD· 2 shared Juan Luis Pacheco‐GarcíaiD· 2 shared Albane le MaireiD· 1 shared Amin SagariD· 1 shared Atanasio Gómez‐MulasiD· 1 shared Barbara CelliniiD· 1 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiophysics

Pavla VaňkováORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BiochemistryNucleic Acids ResearchPeer-reviewedSep 23, 2025

New structural insights into the control of the retinoic acid receptors RAR/RXR by DNA, ligands and transcriptional coregulators

Izabella Tambones, Amin Sagar, Pavla Vaňková…·Albane le Maire

This study reveals how DNA sequence and ligand binding influence the structural dynamics of RAR/RXR-coregulator complexes through integrative structural analysis.

10 citations

structural biologyexperimental assay

𝕏 PostBluesky

BiophysicsbioRxivPreprintApr 12, 2025

Nanobodies as therapies for loss-of-function misfolding diseases.

Atanasio Gómez‐Mulas, Mirco Dindo, Juan Luis Pacheco‐García…·Angel Luis Pey

This study develops and characterizes six nanobodies as potential therapeutics for PH1 by targeting misfolded AGT variants, showing high affinity and functional enhancement in cellular models.

DOI 10.1101/2025.04.12.648492

humanprotein structure

𝕏 PostBluesky

BiophysicsbioRxivPreprintFeb 2, 2025

Active site tyrosine residues in human NQO1 homodimer are critical for non-synchronous enzyme catalysis at the two active sites.

Maribel Rivero, Juan Luis Pacheco‐García, Pavla Vaňková…·Angel Luis Pey

This study investigates the role of Tyr126 and Tyr128 in human NQO1 catalysis, showing their critical impact on enzyme activity and non-synchronous catalysis.

DOI 10.1101/2025.02.02.636097

humanexperimental assay

𝕏 PostBluesky